DRMA · ISSUER CIK 1853816
Dermata Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 2 Dermata Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 18, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18, 202617:25 | Aug 16, 2026 | DRMA | PRESIDENT, CHAIRMAN, CEO, Director, 10% Owner | A · Grant | — | +170,068 | 292,631 | +139% | — | ||
| Aug 18, 202617:21 | Aug 16, 2026 | DRMA | SVP, CFO | A · Grant | — | +102,040 | 232,463 | +78% | — |